Fig. 7 | Scientific Reports

Fig. 7

From: Triple synergistic enhancement of breast cancer treatment via chemotherapy, chemodynamic therapy, and tumor starvation therapy driven by lipid-COF nanoparticles

Fig. 7

The safety analysis of Cur/Gox@LCOF. (A) Hemolysis analysis of Cur/Gox@LCOF. (B-G) Blood routine and blood biochemistry results of mice treated with Cur/Gox@LCOF. (H) H&E staining images of dissected major organs (heart, liver, spleen, lung, kidney) of 4T1 tumor-bearing mice after various treatments for 14 days by intravenous administration.

Back to article page